Skip to main content
. 2023 Feb 7;15(2):550. doi: 10.3390/pharmaceutics15020550

Figure 4.

Figure 4

SOD1 activity in lacrimal fluid after single instillation of SOD1-containing hybrid particles (blue) and SOD1 solution (grey).